We recently found that stimulation of human pancreatic cancer cells with a combination of the GPCR agonist neurotensin and insulin induces a marked increase in YAP phosphorylation at Tyr357, which was prevented by exposure to SFK inhibitors. The gene discussed is YAP1; the disease is pancreatic neoplasm.